Drug Profile
Multiple sclerosis vaccine - Connetics Corporation
Alternative Names: TCR peptide multiple sclerosis vaccineLatest Information Update: 01 Jun 1998
Price :
$50
*
At a glance
- Originator Connetics Corporation
- Class Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Multiple sclerosis